446 related articles for article (PubMed ID: 31626279)
1. Computational approaches to therapeutic antibody design: established methods and emerging trends.
Norman RA; Ambrosetti F; Bonvin AMJJ; Colwell LJ; Kelm S; Kumar S; Krawczyk K
Brief Bioinform; 2020 Sep; 21(5):1549-1567. PubMed ID: 31626279
[TBL] [Abstract][Full Text] [Related]
2. Computer-Aided Antibody Design: An Overview.
Choong YS; Lee YV; Soong JX; Law CT; Lim YY
Adv Exp Med Biol; 2017; 1053():221-243. PubMed ID: 29549642
[TBL] [Abstract][Full Text] [Related]
3. An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.
Guest JD; Vreven T; Zhou J; Moal I; Jeliazkov JR; Gray JJ; Weng Z; Pierce BG
Structure; 2021 Jun; 29(6):606-621.e5. PubMed ID: 33539768
[TBL] [Abstract][Full Text] [Related]
4. Analysis of interleukin 23 and 7G10 interactions for computational design of lead antibodies against immune-mediated inflammatory diseases.
Saba Khan N; Verma R; Pradhan D; Nayek A; Bhuyan R; Kumar Sahu T; Kumar Jain A
J Recept Signal Transduct Res; 2018 Aug; 38(4):327-334. PubMed ID: 30481093
[TBL] [Abstract][Full Text] [Related]
5. Computational Tools for Aiding Rational Antibody Design.
Krawczyk K; Dunbar J; Deane CM
Methods Mol Biol; 2017; 1529():399-416. PubMed ID: 27914064
[TBL] [Abstract][Full Text] [Related]
6. Modeling Antibody-Antigen Complexes by Information-Driven Docking.
Ambrosetti F; Jiménez-García B; Roel-Touris J; Bonvin AMJJ
Structure; 2020 Jan; 28(1):119-129.e2. PubMed ID: 31727476
[TBL] [Abstract][Full Text] [Related]
7. Toward rational antibody design: recent advancements in molecular dynamics simulations.
Yamashita T
Int Immunol; 2018 Apr; 30(4):133-140. PubMed ID: 29346652
[TBL] [Abstract][Full Text] [Related]
8. Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design.
Cannon DA; Shan L; Du Q; Shirinian L; Rickert KW; Rosenthal KL; Korade M; van Vlerken-Ysla LE; Buchanan A; Vaughan TJ; Damschroder MM; Popovic B
PLoS Comput Biol; 2019 May; 15(5):e1006980. PubMed ID: 31042706
[TBL] [Abstract][Full Text] [Related]
9. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
Nilvebrant J; Dunlop DC; Sircar A; Wurch T; Falkowska E; Reichert JM; Helguera G; Piccione EC; Brack S; Berger S
MAbs; 2012; 4(2):153-81. PubMed ID: 22453091
[TBL] [Abstract][Full Text] [Related]
10. IsAb: a computational protocol for antibody design.
Liang T; Chen H; Yuan J; Jiang C; Hao Y; Wang Y; Feng Z; Xie XQ
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33876197
[TBL] [Abstract][Full Text] [Related]
11. Computational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer Therapy.
Melo R; Lemos A; Preto AJ; Almeida JG; Correia JDG; Sensoy O; Moreira IS
Curr Top Med Chem; 2018; 18(13):1091-1109. PubMed ID: 30068276
[TBL] [Abstract][Full Text] [Related]
12. Optimization of protein-protein docking for predicting Fc-protein interactions.
Agostino M; Mancera RL; Ramsland PA; Fernández-Recio J
J Mol Recognit; 2016 Nov; 29(11):555-568. PubMed ID: 27445195
[TBL] [Abstract][Full Text] [Related]
13. In silico site-directed mutagenesis of neutralizing mAb 4C4 and analysis of its interaction with G-H loop of VP1 to explore its therapeutic applications against FMD.
Sahu TK; Pradhan D; Rao AR; Jena L
J Biomol Struct Dyn; 2019 Jul; 37(10):2641-2651. PubMed ID: 30051760
[TBL] [Abstract][Full Text] [Related]
14. Machine learning in computational docking.
Khamis MA; Gomaa W; Ahmed WF
Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Epitope Binding Regions of Entire Antibody Panels by Combining Experimental and Computational Analysis of Antibody: Antigen Binding Competition.
Brooks BD; Closmore A; Yang J; Holland M; Cairns T; Cohen GH; Bailey-Kellogg C
Molecules; 2020 Aug; 25(16):. PubMed ID: 32796656
[TBL] [Abstract][Full Text] [Related]
16. Computational Modelling of Protein Complex Structure and Assembly.
Wells JN; Bergendahl LT; Marsh JA
Methods Mol Biol; 2018; 1764():347-356. PubMed ID: 29605926
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies, act two: new molecules for new challenges].
Dutertre CA; Teillaud JL
J Soc Biol; 2006; 200(4):377-86. PubMed ID: 17652973
[TBL] [Abstract][Full Text] [Related]
18. Prediction and Reduction of the Aggregation of Monoclonal Antibodies.
van der Kant R; Karow-Zwick AR; Van Durme J; Blech M; Gallardo R; Seeliger D; Aßfalg K; Baatsen P; Compernolle G; Gils A; Studts JM; Schulz P; Garidel P; Schymkowitz J; Rousseau F
J Mol Biol; 2017 Apr; 429(8):1244-1261. PubMed ID: 28322916
[TBL] [Abstract][Full Text] [Related]
19. Research and development of next generation of antibody-based therapeutics.
Li J; Zhu Z
Acta Pharmacol Sin; 2010 Sep; 31(9):1198-207. PubMed ID: 20694021
[TBL] [Abstract][Full Text] [Related]
20. Computational methods to predict therapeutic protein aggregation.
Buck PM; Kumar S; Wang X; Agrawal NJ; Trout BL; Singh SK
Methods Mol Biol; 2012; 899():425-51. PubMed ID: 22735968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
